DARS Human

Aspartyl-tRNA Synthetase Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular and Genetic Characteristics

  • Gene structure: The DARS gene (MIM 603084) encodes a 501-amino acid protein with 96% homology to its murine ortholog .

  • Functional domains: The enzyme contains an N-terminal tRNA-binding domain and a C-terminal catalytic domain critical for aminoacylation . Mutations in the catalytic domain (e.g., p.Asp376Tyr, p.Ala274Val) disrupt aspartyl-tRNA synthesis, impairing translation .

  • Evolutionary conservation: High conservation across species enables cross-species modeling of HBSL .

Regional Expression in the Human Brain

DARS exhibits distinct expression gradients in the CNS, as shown by qRT-PCR and Western blot analyses of post-mortem brain tissue :

Brain RegionDARS mRNA (Relative to Cortex)DARS Protein (Relative to Cortex)
Cerebellum (CB)2.5× ↑1.5–2.0× ↑
Hippocampus (HC)1.2× ↑1.1× ↑
Brainstem (BS)1.0×1.0×
Corpus Callosum (CC)0.8× ↓0.7× ↓

Key findings:

  • Cerebellar DARS levels are 50–100% higher than in other regions, correlating with HBSL-associated cerebellar dysfunction .

  • Neurons show 3–5× higher DARS expression than oligodendrocytes or astrocytes, explaining white matter vulnerability in HBSL .

Cellular Localization and Pathomechanisms

Immunohistochemistry reveals cell-type-specific expression patterns :

  • Neurons: Strong cytoplasmic staining in Purkinje cells (cerebellum), hippocampal pyramidal neurons, and cortical layers III–V.

  • Glial cells: Weak expression in oligodendrocytes (<20% of neuronal levels) and astrocytes.

HBSL-associated mutations (e.g., c.821C>T, c.1363T>C) reduce enzyme activity by disrupting active-site residues (Figure 2 ):

  • p.Ala274Val: Alters a conserved residue in the tRNA-binding domain, reducing tRNA affinity .

  • p.Tyr455His: Distorts the catalytic pocket, decreasing aspartylation efficiency by >70% .

Disease Biomarkers

HBSL patients exhibit:

  • Hypomyelination in corticospinal tracts and cerebellar peduncles .

  • Elevated neurofilament light chain (NfL) in CSF, correlating with disease severity .

Therapeutic Strategies

  • Gene therapy: AAV9-mediated DARS delivery rescues myelination defects in murine models .

  • Pharmacological chaperones: In silico screens identify compounds stabilizing mutant DARS (e.g., betaine) .

Methodological Advances in DARS Research

  • Omics integration: RNA-seq and proteomics quantify DARS expression across 15 CNS subregions .

  • Cryo-EM: Resolves DARS-tRNA interactions at 2.8 Å, guiding mutation analysis .

  • Stem cell models: Patient-derived neurons recapitulate tRNA mischarging and ER stress .

Future Directions

  1. Neuron-targeted therapies: Leveraging AAV capsids to bypass blood-brain barriers .

  2. Biomarker validation: PD biomarkers (e.g., tRNA-Asp pools) for clinical trial monitoring .

  3. Global registries: COLLABORATE-HBSL initiative standardizes genotype-phenotype correlations .

Product Specs

Introduction
DARS, also known as aspartyl-tRNA synthetase, catalyzes a two-step reaction to attach an aspartate amino acid to its corresponding tRNA molecule. In the first step, the aspartate is activated by ATP, forming aspartyl-AMP. Subsequently, the aspartate moiety is transferred to the acceptor end of the tRNA.
Description
Recombinant DARS, produced in E. coli, is a single polypeptide chain with a molecular weight of 59.3 kDa. It consists of 521 amino acids, with the first 501 amino acids corresponding to the DARS protein. A 20 amino acid His-tag is fused to the N-terminus to facilitate purification using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution that has been sterilized by filtration.
Formulation
The DARS solution is provided at a concentration of 1 mg/ml in a buffer containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM DTT, and 40% glycerol.
Stability
For short-term storage (2-4 weeks), the DARS solution can be stored at 4°C. For long-term storage, it is recommended to store the solution at -20°C. Adding a carrier protein like 0.1% HSA or BSA is advisable for long-term storage. Avoid repeated freezing and thawing of the solution.
Purity
The purity of the DARS protein is greater than 85%, as determined by SDS-PAGE analysis.
Synonyms
Aspartyl-tRNA synthetase, Cell proliferation-inducing gene 40 protein, AspRS, aspartate tRNA ligase 1 cytoplasmic, EC 6.1.1.12.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MPSASASRKS QEKPREIMDA AEDYAKERYG ISSMIQSQEK PDRVLVRVRD LTIQKADEVV WVRARVHTSR AKGKQCFLVL RQQQFNVQAL VAVGDHASKQ MVKFAANINK ESIVDVEGVV RKVNQKIGSC TQQDVELHVQ KIYVISLAEP RLPLQLDDAV RPEAEGEEEG RATVNQDTRL DNRVIDLRTS TSQAVFRLQS GICHLFRETL INKGFVEIQT PKIISAASEG GANVFTVSYF KNNAYLAQSP QLYKQMCICA DFEKVFSIGP VFRAEDSNTH RHLTEFVGLD IEMAFNYHYH EVMEEIADTM VQIFKGLQER FQTEIQTVNK QFPCEPFKFL EPTLRLEYCE ALAMLREAGV EMGDEDDLST PNEKLLGHLV KEKYDTDFYI LDKYPLAVRP FYTMPDPRNP KQSNSYDMFM RGEEILSGAQ RIHDPQLLTE RALHHGIDLE KIKAYIDSFR FGAPPHAGGG IGLERVTMLF LGLHNVRQTS MFPRDPKRLT P.

Q&A

What is DARS and what role does it play in human neurological function?

DARS (cytoplasmic aspartyl-tRNA synthetase) is an essential enzyme that pairs aspartate with its corresponding tRNA during protein synthesis. This fundamental cellular process is crucial for proper protein translation throughout the body, but DARS shows particularly high expression in brain tissue .

DARS functions as a dimer with an N-terminal anticodon recognition domain and a C-terminal catalytic domain. As a core component of the translational machinery, it is diffusely localized in the cytoplasm and broadly expressed in the central nervous system .

Research methodology approach: When studying DARS function, researchers should employ both protein expression analysis and gene transcription studies across different brain regions. Immunostaining techniques have revealed that DARS is highly expressed in specific brain regions including:

Brain RegionDARS Expression Level
CerebellumHigh
Brain stemHigh
ThalamencephalonModerate to High
HippocampusHigh
Basal gangliaModerate
Spinal cordModerate to High

What ethical frameworks govern human research involving DARS studies?

Human research involving DARS studies must adhere to established ethical frameworks that protect participants' rights and welfare. Research institutions typically establish Human Research Review Committees (HRRC) to ensure compliance with federal and state regulations .

Key methodological considerations include:

  • Following the Belmont Report principles: Respect for Persons, Beneficence, and Justice

  • Ensuring informed consent is properly obtained without coercion

  • Minimizing risks to subjects while maximizing potential benefits

  • Designing scientifically sound research that will not unnecessarily expose subjects to risk

When planning DARS research involving human subjects, researchers must determine whether their work constitutes human research by evaluating if it is "a systematic investigation designed to develop or contribute to generalizable knowledge" and involves obtaining data through intervention/interaction with living individuals or accessing identifiable private information .

What are the key experimental design considerations for studying DARS mutations?

When designing experiments to investigate DARS mutations, researchers should consider several methodological approaches:

  • Genetic sequencing methods:

    • Targeted next-generation sequencing

    • Whole-exome sequencing

    • Sanger sequencing for validation

  • Expression analysis techniques:

    • mRNA expression analysis across brain regions

    • Protein-level expression studies

    • Cell-type specific expression patterns

  • Imaging modalities:

    • MRI to identify hypomyelination patterns in white matter

    • Spinal cord imaging to detect signal abnormalities

  • Sample considerations:

    • Include both affected individuals and family members

    • Collect comprehensive clinical data and imaging findings

    • Consider ethical implications of genetic testing on family members

A robust experimental design should incorporate control procedures to minimize bias and validate findings. For example, the study described in search result utilized multiple sequencing approaches and confirmed variants through different methods, comparing them against established databases to determine pathogenicity.

How do researchers analyze contradictions in DARS-related data?

Data contradictions are common in complex research areas like DARS studies. Rather than viewing contradictions as problematic, researchers should embrace them as valuable opportunities for deeper insight . A systematic approach to analyzing contradictions includes:

  • Contradiction pattern identification:
    Define the parameters of contradictions using notation systems such as (α, β, θ) where:

    • α represents the number of interdependent items

    • β represents the number of contradictory dependencies defined by domain experts

    • θ represents the minimal number of required Boolean rules to assess contradictions

  • Boolean minimization techniques:
    Apply Boolean logic to reduce complex contradiction patterns to their minimal form, which may significantly lower the number of rules needed to assess contradictions .

  • Cross-validation methods:
    Implement split-sample cross-validation to confirm whether contradictory findings are due to sampling error or represent genuine biological complexity .

  • Meta-analytical approaches:
    When multiple studies produce contradictory results using the same dataset, implement sequential correction of alpha values to control false positive rates .

As noted in research on data quality: "While there might be a different number of contradictions formulated by the domain experts, we are confident that such a notation and structured analysis of the contradiction patterns helps to handle the complexity of multidimensional interdependencies within health data sets" .

What are the molecular mechanisms of DARS mutations in HBSL pathogenesis?

Hypomyelination with Brain Stem and Spinal Cord involvement and Leg spasticity (HBSL) is caused by mutations in the DARS1 gene. Understanding the molecular mechanisms requires sophisticated research approaches:

  • Mutation location analysis:
    The mutations identified in HBSL patients typically lie in the 3′ third of DARS, corresponding to the C-terminal active-site domain . Specific mutations documented include:

    MutationProtein ChangeOriginPathogenicity
    c.1363T>Cp.Y455HMaternalPathogenic
    c.821C>Gp.A274GPaternalLikely pathogenic
  • Cellular expression studies:
    Research has revealed cell-type specific effects of DARS mutations. DARS shows distinct expression patterns with:

    • Enrichment in neurons

    • Lower abundance in oligodendrocytes (cells critical for myelination)

    • Low expression in astrocytes and microglia

  • Mechanistic investigation methods:
    To understand how mutations affect DARS function, researchers employ:

    • Enzyme activity assays to measure aminoacylation function

    • Protein structural modeling to assess how mutations impact protein folding

    • Cell culture models using patient-derived cells

    • Human stem cell-derived neurons, oligodendrocytes, and astrocytes

The pathophysiological mechanism likely involves impaired DARS expression in oligodendrocytes, leading to defective myelination: "Oligodendrocyte plays an important role in myelination; hence DARS gene mutation results in the demyelination of white matter by decreasing the expression of endogenous DARS in oligodendrocytes" .

How can researchers address data overuse issues in DARS-related longitudinal studies?

Data overuse is a significant concern in research, particularly for longitudinal studies investigating rare disorders like DARS-related HBSL. Methodological approaches to mitigate this issue include:

  • Dependency identification:
    Track and manage dependency among published findings by maintaining comprehensive metadata about dataset usage in publications .

  • Sequential alpha correction:
    Implement "alpha debt" approaches that extend the adjustment of alpha criteria via Bonferroni correction to all publications using the same dataset .

  • Sample refreshment strategies:
    Consider refreshing samples with new cohorts, though this is resource-intensive. Few studies have successfully implemented this approach .

  • Cross-validation techniques:
    Employ holdout samples and split-sample cross-validation to validate findings internally before publication .

  • Transparent reporting:
    When using the same dataset for multiple analyses, explicitly cite previous uses and explain analytical differences that might lead to contradictory findings .

As noted in research: "Overuse of publicly-available datasets creates dependency among published research papers giving the false impression of independent contributions to knowledge by reporting the same associations over multiple papers" . This is particularly relevant for rare conditions like HBSL, where limited patient populations may lead to repeated analysis of the same datasets.

What advanced imaging and experimental techniques are emerging for DARS research?

Cutting-edge research on DARS and associated disorders employs sophisticated technical approaches:

  • Advanced neuroimaging protocols:

    • High-resolution MRI to characterize hypomyelination patterns

    • Diffusion tensor imaging to assess white matter tract integrity

    • Functional MRI to correlate structural changes with neurological function

  • Multi-omics integration:

    • Combining genomics, transcriptomics, and proteomics data

    • Correlating mutation data with expression profiles across brain regions

    • Integrating clinical phenotypes with molecular signatures

  • Brain organoid models:

    • Development of 3D brain organoids carrying DARS mutations

    • Studying developmental trajectories in controlled conditions

    • Testing potential therapeutic approaches in these models

  • Single-cell analysis techniques:

    • Single-cell RNA sequencing to identify cell-specific expression patterns

    • Analysis of DARS expression in oligodendrocyte lineage cells at different developmental stages

The application of these advanced techniques requires careful experimental design: "A prerequisite for translation is the accurate charging of tRNAs with their cognate amino acids, a reaction catalyzed by specific aminoacyl-tRNA synthetases. One of these enzymes is the aspartyl-tRNA synthetase DARS, which pairs aspartate with its corresponding tRNA" .

What methodological approaches should be used when studying DARS expression across different human cell types?

When investigating DARS expression patterns across human cell types, researchers should employ rigorous methodological approaches:

  • Cell isolation techniques:

    • FACS sorting of specific cell populations from brain tissue

    • Laser capture microdissection for region-specific analysis

    • Single-cell isolation methods for individual cell type examination

  • Expression quantification methods:

    • RT-qPCR for mRNA quantification

    • Western blotting and immunohistochemistry for protein detection

    • RNA sequencing for comprehensive transcriptomic profiling

  • Human stem cell-derived models:
    Analysis of DARS expression can be performed in:

    • Human stem cell-derived neurons

    • Human stem cell-derived oligodendrocytes

    • Human stem cell-derived astrocytes

  • Comparative analysis framework:

    • Statistical methods to compare expression levels between cell types

    • Normalization procedures appropriate for brain tissue

    • Controls for experimental variability

Research has shown that "DARS expression is significantly enriched in the cerebellum, a region affected in HBSL patients and important for motor control. Although obligatorily expressed in all cells, DARS shows a distinct expression pattern with enrichment in neurons but only low abundance in oligodendrocytes, astrocytes, and microglia" .

Product Science Overview

Introduction

Aspartyl-tRNA synthetase (AspRS) is an essential enzyme involved in the translation process of protein synthesis. It belongs to the family of aminoacyl-tRNA synthetases (AARSs), which are responsible for attaching amino acids to their corresponding tRNAs. This process is crucial for the accurate translation of mRNA into proteins. AspRS specifically catalyzes the attachment of aspartic acid to its cognate tRNA, forming aspartyl-tRNA, which is then used in the ribosome during protein synthesis.

Structure and Function

AspRS is a highly conserved enzyme found in all domains of life, including bacteria, archaea, and eukaryotes. In humans, AspRS is encoded by the DARS gene. The enzyme consists of several domains, including the catalytic domain responsible for the aminoacylation reaction and additional domains that may be involved in tRNA binding and enzyme regulation.

The primary function of AspRS is to ensure the correct pairing of aspartic acid with its corresponding tRNA. This process involves two main steps:

  1. Activation of Aspartic Acid: AspRS catalyzes the reaction between aspartic acid and ATP, forming aspartyl-adenylate and releasing pyrophosphate.
  2. Transfer to tRNA: The activated aspartic acid is then transferred to the 3’ end of the tRNA, forming aspartyl-tRNA.
Recombinant AspRS

Recombinant AspRS refers to the enzyme produced through recombinant DNA technology. This involves cloning the DARS gene into an expression vector, introducing it into a host organism (such as E. coli), and inducing the expression of the enzyme. The recombinant enzyme can then be purified for various applications, including biochemical studies, structural analysis, and therapeutic research.

Applications and Importance

AspRS plays a critical role in protein synthesis, and its malfunction can lead to various diseases. Mutations in the DARS gene have been associated with hypomyelination with brain stem and spinal cord involvement and leg spasticity (HBSL), a rare neurological disorder. Understanding the structure and function of AspRS is essential for developing potential therapeutic interventions for such conditions.

Recombinant AspRS is also valuable in research settings. It allows scientists to study the enzyme’s properties, investigate its interactions with other molecules, and explore its role in cellular processes. Additionally, recombinant AspRS can be used in high-throughput screening assays to identify potential inhibitors or modulators of the enzyme, which could lead to the development of new drugs.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.